ClearPoint Neuro (CLPT) EBT Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.59% |
| Dec 31, 2025 | -25.81% |
| Sep 30, 2025 | -31.91% |
| Jun 30, 2025 | -28.30% |
| Mar 31, 2025 | -23.98% |
| Dec 31, 2024 | -26.89% |
| Sep 30, 2024 | -34.58% |
| Jun 30, 2024 | -23.13% |
| Mar 31, 2024 | -27.49% |
| Dec 31, 2023 | -31.06% |
| Sep 30, 2023 | -27.51% |
| Jun 30, 2023 | -30.50% |
| Mar 31, 2023 | -27.81% |
| Sep 30, 2021 | -15.72% |
| Jun 30, 2021 | -9.62% |
| Mar 31, 2021 | -2.01% |
| Sep 30, 2020 | 8.05% |
| Jun 30, 2020 | 10.97% |
| Mar 31, 2020 | 8.77% |
| Dec 31, 2019 | 11.14% |
| Sep 30, 2019 | 17.30% |
| Jun 30, 2019 | 9.05% |
| Mar 31, 2019 | -21.06% |
| Dec 31, 2018 | 16.83% |
| Sep 30, 2018 | 6.03% |
| Jun 30, 2018 | 3.91% |
| Mar 31, 2018 | 9.22% |
| Sep 30, 2016 | 1.83% |
| Jun 30, 2016 | -2.18% |
| Mar 31, 2016 | -0.24% |